2Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer[J].N Engl J Med,2002,346(2):85-91.
3Socinski M,Weissman C,Hart L,et al.Randomized phase II trial of pemetrexed combined with either cisplatin or arboplatin in untreated extensive-stage small-lung cancer[J].Proc Am Soc Clin Oncol,2006,24(30):4840-4847.
5Johnson BE.Potentially effective targeted agents for patients with small-cell lung cancer[C].ASCO Education book,2006,449.
6Wakelle H,Kelly K.Novel approached for the treatment of small cell lung cancer[J].Hematol Oncol Clin North Am,2004,18(2):499-518.
7Zakowski MF,Ladanyi M,Kris MG.EGFR mutations in small-cell lung cancers in patients who have never smoked[J].N Engl J Med,2006,355(2):213-215.
8Moore AM,Einhorn LH,Estes D,et al.Gefitinib in patients with chemosensitive and chemo-refractory relapsed small cell cancers:a Hoosier Oncology Group phase II trial[J].Lung Cancer.2006,52(1):93-97.
9Micke P,Basrai M,Faldum A,et al.Characterization of c-Kit expression in small cell lung cancer:prognostic and therapeutic implications[J].Clin Cancer Res,2003,9(1):188-194.
10Naeem M,Dahiya M,Clark JI,et al.Analysis of c-Kit protein expression in small-cell lung carcinoma and its implication for prognosis[J].Hum Pathol.2002,33(12):1182-1187.
